Previous studies have shown that overexpression of PD-L1 in cancers such as gastric cancer, hepatocellular carcinoma, renal cell carcinoma and esophageal cancer, pancreatic cancer and bladder cancer is related to poor prognosis. This evidence concerns the gene CD274 and renal cell carcinoma.